FDA Approves Axatilimab-csfr In 9 Mg, 22 Mg Vial Sizes To Treat Adult And Pediatric Patients With GVHD
- January 17, 2025
You must be logged in to access this content.
Health Law Daily
You must be logged in to access this content.